Cardiology 101
-
Acute Coronary Syndrome (ACS)
Acute Coronary Syndrome (ACS) Pharmacotherapy: A Focus on STEMI10 Topics|3 Quizzes-
Pre-Quiz for STEMI Pharmcotherapy
-
Background in STEMI
-
Diagnostic Evaluation in STEMI
-
Antiplatelet Therapy in STEMI
-
Glycoprotein IIb/IIIa inhibitors in STEMI
-
Anticoagulants in STEMI
-
Ancillary Therapies in STEMI
-
Reperfusion Therapies in STEMI
-
Literature Review: STEMI Pharmacotherapy
-
Summary and Key Points in STEMI
-
Pre-Quiz for STEMI Pharmcotherapy
-
HypertensionHypertensive Urgency and Emergency Management11 Topics|3 Quizzes
-
Pre-Quiz: Hypertensive Urgency and Emergency Management
-
Introduction: Hypertensive Urgency and Emergency Management
-
Clinical Presentation: Hypertensive Urgency and Emergency Management
-
Pathophysiology: Hypertensive Urgency and Emergency Management
-
Diagnostic Approach: Hypertensive Urgency and Emergency Management
-
Management - Overview: Hypertensive Urgency and Emergency Management
-
Hypertensive Urgency Pharmacotherapy
-
Hypertensive Emergency Pharmacotherapy
-
Literature Review: Hypertensive Urgency and Emergency Management
-
Summary: Hypertensive Urgency and Emergency Management
-
References and Bibliography: Hypertensive Urgency and Emergency Management
-
Pre-Quiz: Hypertensive Urgency and Emergency Management
-
Chronic Hypertension Pharmacotherapy10 Topics|3 Quizzes
-
Heart FailureAcute Decompensated Heart Failure Pharmacotherapy10 Topics|3 Quizzes
-
Chronic Heart Failure Pharmacotherapy10 Topics|3 Quizzes
Quizzes
Participants 396
Pathophysiology
The pathophysiology of ADHF involves a complex interplay of cardiac dysfunction, fluid overload, and neurohormonal activation. It typically begins with an insult that disrupts the equilibrium of chronic heart failure or triggers a new cardiac event. This can include factors such as dietary indiscretion, medication nonadherence, acute illness, or the development of a new cardiac condition like myocardial infarction or atrial fibrillation.
The underlying cardiac dysfunction, characterized by impaired contractility and ventricular remodeling, leads to reduced cardiac output and inadequate tissue perfusion. This triggers compensatory mechanisms, such as activation of the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system, resulting in vasoconstriction, sodium and water retention, and increased preload and afterload. These neurohormonal responses aim to maintain cardiac output, but they can contribute to further cardiac damage and exacerbate fluid overload.
In addition, the elevated ventricular filling pressures caused by fluid overload lead to pulmonary and systemic venous congestion. Symptoms like dyspnea and peripheral edema result from this backward failure. Impaired perfusion to vital organs caused by reduced cardiac output manifests as fatigue, altered mental status, and worsening renal function. Patients may present with signs and symptoms of both fluid overload and hypoperfusion.